SEC Form 4 research

Roka BioScience, Inc. insider transactions

Inspect Roka BioScience, Inc.'s public SEC insider acquisitions and sales, reporting owners and source receipts.

As of 2026-10-07T00:29:11.873Z

Issuer CIK
0001472343
Reporting owners
31
Officers and directors
5

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

MCGIRR DAVID W J000121902337
BARRETT M JAMES0001219855224
ISALY SAMUEL D0001055949417
ORBIMED ADVISORS LLC00010559511,014
OrbiMed Capital GP III LLC0001432241247
SILVERSTEIN JONATHAN0001171005123

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.